Insulin glulisine

Details

Files

Generic Name:

Insulin glulisine

Project Status:

Complete

Therapeutic Area:

Diabetes, Mellitus (Type 1 & 2)

Manufacturer:

Sanofi-Aventis Canada Inc.

Brand Name:

Apidra

Project Line:

Reimbursement Review

Project Number:

SR0144-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes, Mellitus (Type 1 & 2)

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

February 19, 2009

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : August 29, 2008